Molecular Cancer Therapeutics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindholm, P.
Right arrow Articles by Backlund, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindholm, P.
Right arrow Articles by Backlund, A.
Vol. 1, 365-369, April 2002     Molecular Cancer Therapeutics
© 2002 American Association for Cancer Research

Cyclotides: A Novel Type of Cytotoxic Agents

Petra Lindholm1, Ulf Göransson1, Senia Johansson, Per Claeson, Joachim Gullbo, Rolf Larsson, Lars Bohlin and Anders Backlund2

Division of Pharmacognosy, Department of Medicinal Chemistry, BMC, Uppsala University, S-751 23 [P. L., U. G., S. J., P. C., L. B., A. B.], and Division of Clinical Pharmacology, Department of Medical Sciences, University Hospital, Uppsala University, S-751 85 [J. G., R. L.] Uppsala, Sweden

Cytotoxic activities of three naturally occurring macrocyclic peptides (cyclotides) isolated from the two violets, Viola arvensis Murr. and Viola odorata L., were investigated. A nonclonogenic fluorometric microculture assay was used to examine cytotoxicity in a panel of 10 human tumor cell lines representing defined types of cytotoxic drug resistance. Additionally, primary cultures of tumor cells from patients, and for comparison normal lymphocytes, were used to quantify cytotoxic activity. All three cyclotides, varv A, varv F, and cycloviolacin O2, exhibited strong cytotoxic activities, which varied in a dose-dependent manner. Cycloviolacin O2 was the most potent in all cell lines (IC50 0.1–0.3 µM), followed by varv A (IC50 2.7–6.35 µM) and varv F (IC50 2.6–7.4 µM), respectively. Activity profiles of the cyclotides differed significantly from those of antitumor drugs in clinical use, which may indicate a new mode of action. This, together with the exceptional chemical and biological stability of cyclotides, makes them interesting in particular for their potential as pharmacological tools and possibly as leads to antitumor agents.




This article has been cited by other articles:


Home page
Plant CellHome page
C. W. Gruber, A. G. Elliott, D. C. Ireland, P. G. Delprete, S. Dessein, U. Goransson, M. Trabi, C. K. Wang, A. B. Kinghorn, E. Robbrecht, et al.
Distribution and Evolution of Circular Miniproteins in Flowering Plants
PLANT CELL, September 1, 2008; 20(9): 2471 - 2483.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Simonsen, L. Sando, K. J. Rosengren, C. K. Wang, M. L. Colgrave, N. L. Daly, and D. J. Craik
Alanine Scanning Mutagenesis of the Prototypic Cyclotide Reveals a Cluster of Residues Essential for Bioactivity
J. Biol. Chem., April 11, 2008; 283(15): 9805 - 9813.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Saska, A. D. Gillon, N. Hatsugai, R. G. Dietzgen, I. Hara-Nishimura, M. A. Anderson, and D. J. Craik
An Asparaginyl Endopeptidase Mediates in Vivo Protein Backbone Cyclization
J. Biol. Chem., October 5, 2007; 282(40): 29721 - 29728.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
J. P. Mulvenna, J. S. Mylne, R. Bharathi, R. A. Burton, N. J. Shirley, G. B. Fincher, M. A. Anderson, and D. J. Craik
Discovery of Cyclotide-Like Protein Sequences in Graminaceous Crop Plants: Ancestral Precursors of Circular Proteins?
PLANT CELL, September 1, 2006; 18(9): 2134 - 2144.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Chen, M. L. Colgrave, N. L. Daly, K. J. Rosengren, K. R. Gustafson, and D. J. Craik
Isolation and Characterization of Novel Cyclotides from Viola hederaceae: SOLUTION STRUCTURE AND ANTI-HIV ACTIVITY OF vhl-1, A LEAF-SPECIFIC EXPRESSED CYCLOTIDE
J. Biol. Chem., June 10, 2005; 280(23): 22395 - 22405.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Hillger, G. Herr, R. Rudolph, and E. Schwarz
Biophysical Comparison of BMP-2, ProBMP-2, and the Free Pro-peptide Reveals Stabilization of the Pro-peptide by the Mature Growth Factor
J. Biol. Chem., April 15, 2005; 280(15): 14974 - 14980.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
M. Trabi and D. J. Craik
Tissue-Specific Expression of Head-to-Tail Cyclized Miniproteins in Violaceae and Structure Determination of the Root Cyclotide Viola hederacea root cyclotide1
PLANT CELL, August 1, 2004; 16(8): 2204 - 2216.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Nourse, M. Trabi, N. L. Daly, and D. J. Craik
A Comparison of the Self-association Behavior of the Plant Cyclotides Kalata B1 and Kalata B2 via Analytical Ultracentrifugation
J. Biol. Chem., January 2, 2004; 279(1): 562 - 570.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Goransson and D. J. Craik
Disulfide Mapping of the Cyclotide Kalata B1: CHEMICAL PROOF OF THE CYCLIC CYSTINE KNOT MOTIF
J. Biol. Chem., November 28, 2003; 278(48): 48188 - 48196.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
P. Lindholm, J. Gullbo, P. Claeson, U. Goransson, S. Johansson, A. Backlund, R. Larsson, and L. Bohlin
Selective Cytotoxicity Evaluation in Anticancer Drug Screening of Fractionated Plant Extracts
J Biomol Screen, August 1, 2002; 7(4): 333 - 340.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.